menu
    • menu

    Company profile for Semnur Pharmaceuticals

    NEW Drugs in Dev: 2
    Minakem delivers API, HPAPI, steroids & CDMO services for generics with FDA/GMP certification, regulatory know-how & proven success.

    Virtual Booth

    Contact Supplier

    Boai NKY Pharmaceuticals Ltd. is one of the largest global PVP suppliers.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    Nanjing Well is focused on R&D, production & sales of Pharmaceutical Excipients & Synthetic Lubricating base oils.

    Virtual Booth

    Contact Supplier

    Ever Pharma, highly specialized CDMO in producing complex injectables including high potency & controlled substances, suspensions, etc.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Semnur Pharmaceuticals is focused on advancing innovative therapies for the treatment of pain. Their primary objective is to develop targeted, non-opioid pain management solutions that address significant unmet medical needs. By leveraging proprietary sustained-release technology, Semnur aims to deliver long-lasting pain relief while minimizing systemic exposure and side effects. The company's research and development efforts ...
    Semnur Pharmaceuticals is focused on advancing innovative therapies for the treatment of pain. Their primary objective is to develop targeted, non-opioid pain management solutions that address significant unmet medical needs. By leveraging proprietary sustained-release technology, Semnur aims to deliver long-lasting pain relief while minimizing systemic exposure and side effects. The company's research and development efforts are centered around providing safe and effective alternatives to opioid-based treatments, with a commitment to improving the quality of life for patients suffering from chronic pain conditions.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Semnur PharmaceuticalsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    960 San Antonio Road, Palo Alto, CA, 94303
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.semnurpharma.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    PEGS Boston Summit

    PEGS Boston Summit

    Not Confirmed

    envelop Contact Supplier

    PEGS Boston Summit

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Scilex to Dividend Semnur Pharma Stock to Eligible Holders
    Scilex to Dividend Semnur Pharma Stock to Eligible Holders

    22 May 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/05/22/3300289/0/en/scilex-holding-company-scilex-announces-its-board-of-directors-approved-a-dividend-of-semnur-pharmaceuticals-inc-common-stock-to-holders-of-scilex-common-stock-and-other-eligible-e.html

    GLOBENEWSWIRE
    22 May 2026
    Share Share
    Scilex Closes $200M Semnur Stock-to-Bitcoin Exchange Deal
    Scilex Closes $200M Semnur Stock-to-Bitcoin Exchange Deal

    25 Sep 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/09/25/3156092/0/en/Scilex-Announces-Closing-of-Previously-Announced-Non-Dilutive-Value-Enhancing-Transaction-with-an-Institutional-Investor-for-the-Exchange-of-200-Million-of-Common-Stock-of-Semnur-P.html

    GLOBENEWSWIRE
    25 Sep 2025
    Share Share
    Semnur Pharma, Scilex Subsidiary, And Denali Capital Complete
    Semnur Pharma, Scilex Subsidiary, And Denali Capital Complete

    22 Sep 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/09/22/3154269/0/en/Semnur-Pharmaceuticals-Inc-Semnur-a-Majority-Owned-Subsidiary-of-Scilex-Holding-Company-Nasdaq-SCLX-Scilex-and-Denali-Capital-Acquisition-Corp-Announce-the-Closing-of-Their-Previou.html

    GLOBENEWSWIRE
    22 Sep 2025
    Share Share
    Semnur Pharma, Scilex Majority-Owned Subsidiary, Denali Capital
    Semnur Pharma, Scilex Majority-Owned Subsidiary, Denali Capital

    04 Sep 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/09/04/3144605/0/en/Semnur-Pharmaceuticals-Inc-Semnur-a-Majority-Owned-Subsidiary-of-Scilex-Holding-Company-Nasdaq-SCLX-Scilex-and-Denali-Capital-Acquisition-Corp-Announce-Approval-from-Denali-s-Share.html

    GLOBENEWSWIRE
    04 Sep 2025
    Share Share
    Semnur Pharma Secures $20M Investment for SP-102's Approval
    Semnur Pharma Secures $20M Investment for SP-102's Approval

    21 Aug 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/08/21/3136968/0/en/Scilex-Holding-Company-Nasdaq-SCLX-Announces-Its-Majority-Owned-Subsidiary-Semnur-Pharmaceuticals-Inc-Semnur-and-Denali-Capital-Acquisition-Corp-Have-Entered-into-a-Purchase-Agreem.html

    GLOBENEWSWIRE
    21 Aug 2025
    Share Share
    Scilex Holding Changes Record Date for Preferred Stock Dividend
    Scilex Holding Changes Record Date for Preferred Stock Dividend

    30 Dec 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/12/30/3002700/0/en/Scilex-Holding-Company-Announces-Change-in-Record-Date-for-its-Previously-Announced-Dividend-of-Preferred-Stock-Exchangeable-for-up-to-10-of-Scilex-s-Ownership-Interest-in-Semnur-P.html

    GLOBENEWSWIRE
    30 Dec 2024
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search